CooperCompanies stock steadies ahead of earnings as institutions build positions
Published on 09/06/2026 at 18:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CooperCompanies stock (ISIN US21664P1039) is trading at 69.59 USD as of September 4, 2026 on the New York Stock Exchange, around 15.1 percent below its level of 81.96 USD at the start of the year according to MarketBeat data.
Institutions add exposure before earnings
In the run-up to fresh quarterly figures expected on September 9, 2026, several institutional investors have expanded their exposure to CooperCompanies, giving the stock a notable backdrop despite the weaker year-to-date performance.
According to a MarketBeat overview of recent filings dated September 6, 2026, AXQ Capital LP acquired 14,833 shares of The Cooper Companies during the second quarter, a position valued at about 1,064,000 USD.
The same MarketBeat report highlights that institutions collectively own 24.39 percent of CooperCompanies shares, with large investors such as BlackRock Inc., Generation Investment Management LLP and Diamond Hill Capital Management Inc. building or expanding sizeable positions in recent quarters, underscoring continued professional interest in the medical device group.
Earnings beat sets the stage for next quarter
The upcoming earnings report is scheduled for after the close on September 9, 2026, with CooperCompanies forecast to deliver earnings per share of 1.12 USD on revenue of roughly 1.10 billion USD, according to a TipRanks earnings calendar.
Recent reported figures provide a reference point for these expectations. As summarized by MarketBeat, CooperCompanies most recently posted quarterly earnings per share of 1.21 USD, exceeding estimates of 1.10 USD, while revenue rose 7.9 percent year over year to 1.08 billion USD in that quarter.
This combination of a 0.11 USD EPS beat versus consensus and mid single digit revenue growth gives investors a concrete benchmark when assessing whether the September 9, 2026 release confirms or challenges the current trajectory.
Stock performance and valuation context
Despite the positive earnings surprise in the last reported quarter, CooperCompanies stock has retreated since the start of the year, moving from 81.96 USD to 69.59 USD as of September 4, 2026, a decline of 15.1 percent based on MarketBeat performance data.
MarketBeat also notes that the shares recently opened at 69.59 USD and that CooperCompanies trades within a 12 month range between a low of 58.89 USD and a high of 89.83 USD, placing the current price clearly below the upper end of that bandwidth and closer to the middle of the range.
Analyst sentiment appears cautious but not pessimistic. According to the same MarketBeat compilation, CooperCompanies carries a consensus rating of Hold and an average price target of 81.64 USD, implying potential upside of around 17.3 percent from the latest quoted level of 69.59 USD if the targets are met.
For investors, this mix of subdued year-to-date performance, a price notably under the average target and a recent earnings beat makes the upcoming report a key moment that could either support the Hold stance or prompt recalibration of expectations.
More data and background on CooperCompanies
Investors can find additional corporate news, filings and historical price data on CooperCompanies via the dedicated ISIN overview and the company's own investor relations resources.
Contact lenses remain a key growth driver
CooperCompanies operates with two central business segments, contact lenses and women's health, and remains positioned as a specialist medical technology group rather than a broad diversified healthcare conglomerate.
Within the contact lens segment, marketed under the CooperVision brand, the company addresses demand for daily disposable, toric and multifocal lenses that support patients with myopia, astigmatism and presbyopia, a field where structural growth stems from demographic trends and increasing global access to eye care.
Investors often watch unit growth and mix shifts in these categories, since higher value products, such as daily disposable and specialty lenses, typically support margins and recurring revenue dynamics compared with older monthly replacement technologies.
CooperCompanies stock on the NYSE
CooperCompanies stock is listed on the New York Stock Exchange under the ticker COO and traded in USD, which gives international investors straightforward access via the US market infrastructure.
As of September 4, 2026, MarketBeat data show a closing price of 69.59 USD for COO, within a 12 month band from 58.89 USD to 89.83 USD, indicating that the stock currently trades well below its 12 month high and has room to recover if earnings and guidance sustain confidence.
CooperCompanies at a glance
- Company: CooperCompanies Inc.
- ISIN: US21664P1039
- Ticker: COO
- Trading venue: NYSE
- Price (as of September 4, 2026, 16:00): 69.59 USD
- Market capitalization: 6,000,000,000 USD (as of September 4, 2026)
- Sector / Industry: Medical technology / Healthcare
- Index membership: S&P 500
